Atlas Trials

An Global Comparative Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis

Clinical trial NCT01543503 · COMPLETED

Trial details

NCT number
NCT01543503
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Study type
OBSERVATIONAL
Rheumatoid Arthritis
Start date
2012-02-01
Primary completion
2015-02-01
Enrollment
1225

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.